MedTrace Logo

The Effect of Nonstress Test Device Noise Level on Stress Parameters in Primiparous Pregnant Women

NCT05488704 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2022-08-04

No results posted yet for this study

Summary

Introduction: Prenatal tests can increase the stress levels of pregnant women. One of the tests performed to evaluate fetal health during pregnancy is the Nonstress Test (NST).

Objective: To evaluate the effect of NST device noise level on stress parameters in primiparous pregnant women.

Method: A randomized controlled, prospective study was conducted with 44 pregnant women in a State Hospital in Istanbul/Turkey between 01.02.2021 and 01.10.2021.

Personal Information Form, Spielberger State Anxiety Inventory, Hillrom Welch Allyn Connex Spot Monitor, Gluco Dr Glucometer, Extech SL 400 Personal Noise Dosimeter, Sennheiser HD 450BT ANC Over-Ear Bluetooth Headset, Eppendorf Tube, Philips Avalon FM20 NST were used to collect data. A p value of \<.05 was considered significant in the statistical evaluation.

Conditions

  • Stress
  • Noise Exposure
  • Prenatal Stress
  • Prenatal Care Late
  • Pregnancy Related

Interventions

DIAGNOSTIC_TEST

Stress Parameters Measurement

Pre-Test (0-2 minutes before NST starts) - Measurement of vital parameters (Pre-Test) * Glucose measurement * Taking Salivary Cortisol and Saliva ACTH samples * Filling the Spielberger State Anxiety Inventory • Starting NST by controlling the noise level Interim Test-(NST 10th minute) - Measurement of vital parameters (Intermediate Test) * Taking Salivary Cortisol and Saliva ACTH samples * Filling the Spielberger State Anxiety Inventory • Termination of NST after 20 minutes Final Test(within 0-2 minutes after NST is over) * Measurement of vital parameters * Glucose measurement * Taking Salivary Cortisol and Saliva ACTH samples * Filling the Spielberger State Anxiety Inventory After Data Collection - Recording of data * Centrifugation and analysis of saliva samples taken

Sponsors & Collaborators

  • Halic University

    lead OTHER

Principal Investigators

  • Ayşenur Turan, PhD · Lecturer

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2021-10-01
Completion
2028-07-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05488704 on ClinicalTrials.gov